Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-Step Haploidentical HSCT with Extended Interval for High-Risk Hematologic Malignancies
NCT01341301Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- May 2010
- Primary completion
- Nov 2013
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donor lymphocyte infusion in hematologic malignancy, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2010; status: completed.
02
Drugs
donor lymphocyte infusion
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT01341301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341301.